HMHiroshi Morimatsu

Hiroshi Morimatsu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiroshi Morimatsu has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intraoperative hypotension and postoperative acute kidney injury in patients undergoing prolonged intra-abdominal surgery: a retrospective, observational study

    by Jiyuan Li, Kazuyoshi Shimizu, Ryo Negayama, Hiroshi Morimatsu

    Background: Intraoperative hypotension may be associated with postoperative acute kidney injury (AKI). However, patients undergoing prolonged intra-abdominal surgery may be susceptible to postoperative AKI due to procedure-related physiological changes. Therefore, this study aimed to investigate the association between intraoperative hypotension and the incidence of postoperative AKI in patients undergoing prolonged intra-abdominal surgery with a potentially increased risk of postoperative AKI. Methods: This retrospective, observational study included 269 adult patients who underwent intra-abdominal surgery, with American Society of Anesthesiologists Physical Status (ASA-PS) II–IV, anesthesia duration ≥ 300 min, and preoperative serum creatinine ≥ 0.8 mg/dL. The primary outcome was AKI within the first 7 postoperative days. The associations of intraoperative mean arterial pressure (MAP) less than 55, 60, and 65 mmHg with postoperative AKI were investigated. Multivariable regression models were used to adjust for potential confounding variables. Results: Postoperative AKI occurred in 15 (5.6%) patients. Patients with AKI had longer cumulative durations of intraoperative hypotension defined as MAP < 65 mmHg (103 vs. 46 min, p = 0.031) and < 60 mmHg (24 vs. 11 min, p = 0.035). On multivariable analysis, lower intraoperative urine output was associated with postoperative AKI (adjusted odds ratio 0.226; 95% confidence interval 0.058–0.890, p = 0.033), whereas the association between the cumulative duration of MAP < 65 mmHg and postoperative AKI was no longer statistically significant (adjusted OR 1.054 per 10 min; 95% CI 0.994–1.112; p = 0.076). Conclusion: Intraoperative hypotension was common in patients undergoing prolonged intra-abdominal surgery. Although patients who developed AKI experienced longer cumulative durations of intraoperative hypotension in the unadjusted analysis, an association between intraoperative MAP < 65 mmHg and postoperative AKI was not demonstrated in the multivariable analysis. Lower intraoperative urine output was associated with postoperative AKI. These findings are exploratory and hypothesis-generating.

  • Open Access

    Prediction Model of Extubation Outcomes in Critically Ill Patients: A Multicenter Prospective Cohort Study

    by Aiko Tanaka, Daijiro Kabata, Osamu Hirao, Junko Kosaka, Nana Furushima, Yuichi Maki, Akinori Uchiyama, Moritoki Egi, Ayumi Shintani, Hiroshi Morimatsu, et al.

    Liberation from mechanical ventilation is of great importance owing to related complications from extended ventilation time. In this prospective multicenter study, we aimed to construct a versatile model for predicting extubation outcomes in critical care settings using obtainable physiological predictors. The study included patients who had been extubated after a successful 30 min spontaneous breathing trial (SBT). A multivariable logistic regression model was constructed to predict extubation outcomes (successful extubation without reintubation and uneventful extubation without reintubation or noninvasive respiratory support) using eight parameters: age, heart failure, respiratory disease, rapid shallow breathing index (RSBI), PaO2/FIO2, Glasgow Coma Scale score, fluid balance, and endotracheal suctioning episodes. Of 499 patients, 453 (90.8%) and 328 (65.7%) achieved successful and uneventful extubation, respectively. The areas under the curve for successful and uneventful extubation in the novel prediction model were 0.69 (95% confidence interval (CI), 0.62–0.77) and 0.70 (95% CI, 0.65–0.74), respectively, which were significantly higher than those in the conventional model solely using RSBI (0.58 (95% CI, 0.50–0.66) and 0.54 (95% CI, 0.49–0.60), p = 0.004 and <0.001, respectively). The model was validated using a bootstrap method, and an online application was developed for automatic calculation. Our model, which is based on a combination of generally obtainable parameters, established an accessible method for predicting extubation outcomes after a successful SBT.


  • Open Access

    Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine

    by Yusuke Mizobuchi, Kanako Miyano, Sei Manabe, Eiko Uezono, Akane Komatsu, Yui Kuroda, Miki Nonaka, Yoshikazu Matsuoka, Tetsufumi Sato, Yasuhito Uezono, et al.

    The issue of tolerance to continuous or repeated administration of opioids should be addressed. The ability of ketamine to improve opioid tolerance has been reported in clinical studies, and its mechanism of tolerance may involve improved desensitization of μ-opioid receptors (MORs). We measured changes in MOR activity and intracellular signaling induced by repeated fentanyl and morphine administration and investigated the effects of ketamine on these changes with human embryonic kidney 293 cells expressing MOR using the CellKey™, cADDis cyclic adenosine monophosphate, and PathHunter® β-arrestin recruitment assays. Repeated administration of fentanyl or morphine suppressed the second MOR responses. Administration of ketamine before a second application of opioids within clinical concentrations improved acute desensitization and enhanced β-arrestin recruitment elicited by fentanyl but not by morphine. The effects of ketamine on fentanyl were suppressed by co-treatment with an inhibitor of G-protein-coupled receptor kinase (GRK). Ketamine may potentially reduce fentanyl tolerance but not that of morphine through modulation of GRK-mediated pathways, possibly changing the conformational changes of β-arrestin to MOR.


  • Incidence of accidental events during anesthesia from 2012 to 2016: survey on anesthesia-related events by the Japanese Society of Anesthesiologists

    by Hiroshi Morimatsu

    Purpose The Japanese Society of Anesthesiologists (JSA) has conducted surveys on life-threatening accidental events during anesthesia and reported results since 1992. This report describes the incidence of these life-threatening accidental events in the survey period between 2012 and 2016. Methods JSA conducts an annual survey on accidental events. Each participating facility reports life-threatening accidental events that occurred each year. Facilities accredited by the JSA can electronically report events using the JSA Perioperative Information Management System (JSA-PIMS) software program that interfaces with the electronic anesthesia record system. Results The number of cardiac arrest events per 10,000 anesthesia cases gradually decreased from 2.97 in 2012 to 2.30 in 2016 (odds ratio OR 0.77 95% CI 0.68–0.88). The number of severe hypotension events per 10,000 anesthesia cases gradually decreased from 4.63 in 2012 to 4.24 in 2016 (OR 0.92, 95% CI 0.83–1.01). The number of severe hypoxia events per 10,000 anesthesia cases gradually decreased from 2.01 in 2012 to 1.59 in 2016 (OR 0.79, 95% CI 0.68–0.92). The number of life-threatening arrhythmia events per 10,000 anesthesia cases was 1.14 in 2012. Thereafter, it tended to decrease slightly to 0.88 in 2016 (OR 0.77, 95% CI 0.63–0.95). Conclusion The incidence of cardiac arrest during this period was 2.63/10,000, which was lower the incidence reported in other countries. While no change was observed in the incidence of severe hypotension over the survey period, the incidence of severe hypoxia and life-threatening arrhythmia decreased by 20–25% during those 5 years.


  • Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: A randomized controlled trial

    by Kosei Takagi, Ryuichi Yoshida, Takahito Yagi, Yuzo Umeda, Daisuke Nobuoka, Takashi Kuise, Shiro Hinotsu, Takashi Matsusaki, Hiroshi Morimatsu, Jun Eguchi, et al.


  • Open Access

    Physiological impact of high-flow nasal cannula therapy on postextubation acute respiratory failure after pediatric cardiac surgery: a prospective observational study

    by Naohiro Shioji, Tatsuo Iwasaki, Tomoyuki Kanazawa, Kazuyoshi Shimizu, Tomohiko Suemori, Kentaro Sugimoto, Yasutoshi Kuroe, Hiroshi Morimatsu

    Reintubation after pediatric cardiac surgery is associated with a high rate of mortality. Therefore, adequate respiratory support for postextubation acute respiratory failure (ARF) is important. However, little is known about the physiological impact of high-flow nasal cannula (HFNC) therapy on ARF after pediatric cardiac surgery. Our working hypothesis was that HFNC therapy for postextubation ARF after pediatric cardiac surgery improves hemodynamic and respiratory parameters. This was a prospective observational study conducted at a single university hospital. Children less than 48 months of age who had postextubation ARF after cardiac surgery were included in this study. HFNC therapy was started immediately after diagnosis of postextubation ARF. Data obtained just before starting HFNC therapy were used for pre-HFNC analysis, and data obtained 1 h after starting HFNC therapy were used for post-HFNC analysis. We compared hemodynamic and respiratory parameters between pre-HFNC and post-HFNC periods. The Wilcoxon signed-rank test was used to analyze these indices. Twenty children were included in this study. The median age and body weight were 4.5 (2.3–14.0) months and 4.3 (3.1–7.1) kg, respectively. Respiratory rate (RR) significantly decreased from 43.5 (32.0–54.8) to 28.5 (21.0–40.5) breaths per minute (p = 0.0008) 1 h after the start of HFNC therapy. Systolic blood pressure also decreased from 87.5 (77.8–103.5) to 76.0 (70.3–85.0) mmHg (p = 0.003). Oxygen saturation, partial pressure of arterial carbon dioxide, heart rate, and lactate showed no remarkable changes. There was no adverse event caused by HFNC therapy. HFNC therapy improves the RR of patients who have postextubation ARF after pediatric cardiac surgery without any adverse events.